Influence of microbiota on immunity and immunotherapy for gastric and esophageal cancers

被引：24
|
作者：
Zhang, Xiaoli [1 ]
Pan, Zui [2 ]
机构：
[1] Ohio State Univ, Dept Biomed Informat, Columbus, OH 43201 USA
[2] Univ Texas Arlington, Coll Nursing & Hlth Innovat, Arlington, TX 76010 USA
来源：
GASTROENTEROLOGY REPORT | 2020年 / 8卷 / 03期
基金：
美国国家卫生研究院;
关键词：
dysbiosis; tumor microenvironment; proton-pump inhibitors; antibiotics; checkpoint inhibitors; H; pylori; HELICOBACTER-PYLORI; MOLECULAR CHARACTERIZATION; INTESTINAL METAPLASIA; BACTERIAL BIOTA; GUT MICROBIOME; RISK; INFLAMMATION; THERAPY; EFFICACY; STOMACH;
D O I：
10.1093/gastro/goaa014
中图分类号：
R57 [消化系及腹部疾病];
学科分类号：
摘要：
Gastric and esophageal cancers are multifactorial and multistage-involved malignancy. While the impact of gut microbiota on overall human health and diseases has been well documented, the influence of gastric and esophageal microbiota on gastric and esophageal cancers remains unclear. This review will discuss the reported alteration in the composition of gastric and esophageal microbiota in normal and disease conditions, and the potential role of dysbiosis in carcinogenesis and tumorigenesis. This review will also discuss how dysbiosis stimulates local and systemic immunity, which may impact on the immunotherapy for cancer.
引用
收藏
页码：206 / 214
页数：9
相关论文
共 50 条
  • [31] ABO genotypes and the risk of esophageal and gastric cancers
    Yingxi Chen
    Nan Hu
    Linda Liao
    Kai Yu
    Xiao-Ou Shu
    Wei Zheng
    Jian-Min Yuan
    Woon-Puay Koh
    You-Lin Qiao
    Jin-Hu Fan
    Sanford M. Dawsey
    Neal D. Freedman
    Philip R. Taylor
    Alisa M. Goldstein
    Christian C. Abnet
    BMC Cancer, 21
  • [32] What's New in Gastric and Esophageal Cancers
    Tanabe, Kenneth
    ANNALS OF SURGICAL ONCOLOGY, 2016, 23 (12) : 3773 - 3773
  • [33] The Relationship Between Gastric and Esophageal Cancers in Italy
    Crocetti, Emanuele
    Mancini, Silvia
    Ravaioli, Alessandra
    Giuliani, Orietta
    Bucchi, Lauro
    Falcini, Fabio
    AMERICAN JOURNAL OF GASTROENTEROLOGY, 2016, 111 (08): : 1201 - 1202
  • [34] Updates in Translational Science for Esophageal and Gastric Cancers
    Hompe, Eliza D.
    Sachdeva, Uma M.
    SURGICAL ONCOLOGY CLINICS OF NORTH AMERICA, 2024, 33 (03) : 571 - 581
  • [35] Muscle Attenuation and Sarcopenia in Gastric and Esophageal Cancers
    Geddes, K.
    Rouse, H.
    McLachlan, S. A.
    Sundararajan, V.
    Moore, M.
    ASIA-PACIFIC JOURNAL OF CLINICAL ONCOLOGY, 2017, 13 : 46 - 47
  • [36] Targetting Esophageal and Gastric Cancers with Monoclonal Antibodies
    Norguet, Emmanuelle
    Dahan, Laetitia
    Seitz, Jean-Francois
    CURRENT TOPICS IN MEDICINAL CHEMISTRY, 2012, 12 (15) : 1678 - 1682
  • [37] EPIDEMIOLOGIC FEATURES OF GASTRIC AND ESOPHAGEAL CANCERS IN SLOVAKIA
    MACFARLANE, GJ
    PLESKO, I
    KRAMAROVA, E
    OBSITNIKOVA, A
    BOYLE, P
    BRITISH JOURNAL OF CANCER, 1994, 70 (01) : 177 - 179
  • [38] Endoscopic mucosal resection for esophageal and gastric cancers
    Inoue, H
    Fukami, N
    Yoshida, T
    Kudo, SE
    JOURNAL OF GASTROENTEROLOGY AND HEPATOLOGY, 2002, 17 (04) : 382 - 388
  • [39] The emerging role of immunotherapy in gastric and esophageal adenocarcinoma
    Bockorny, Bruno
    Pectasides, Eirini
    FUTURE ONCOLOGY, 2016, 12 (15) : 1833 - 1846
  • [40] Gut Microbiota Influence Immunity to Vaccination
    不详
    HUMAN VACCINES & IMMUNOTHERAPEUTICS, 2014, 10 (11) : 3104 - 3104
12345